Solid Biosciences Inc (SLDB)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| CEO: | Ilan Ganot |
| Employees: | 100 |
| Web site: | solidbio.com |
|
500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
617-337-4680
| |
| Date | Ratio |
|---|---|
| 2022-10-28 | 1:15 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles.
Please log in first to see chart